Inventor · disambiguated record
Mihriban Tuna
Also filed as: TUNA MIHRIBAN
14 granted patents·12 pending applications·55 citations·filing 2007–2025
90Inventor score
Files withINVOX PHARMA LTD7F STAR BETA LTD5F STAR THERAPEUTICS LTD5F STAR DELTA LTD2GAMMADELTA THERAPEUTICS LTD2
Top patents by PatentIndex Score
26 records- 0190US11214618B2LAG-3 binding membersF STAR BETA LTD·Filed 2017·Granted Jan 4, 2022·11 cites·20 claims
- 0289US11214620B2Binding molecules binding PD-L1 and LAG-3F STAR DELTA LTD·Filed 2017·Granted Jan 4, 2022·11 cites·20 claims
- 0387US11548948B2FC binding fragments comprising a PD-L1 antigen-binding siteF STAR BETA LTD·Filed 2018·Granted Jan 10, 2023·9 cites·21 claims
- 0486US11629189B2Bispecific antibody for ICOS and PD-L1KYMAB LTD·Filed 2018·Granted Apr 18, 2023·4 cites·27 claims
- 0585US12187798B2LAG-3 binding membersF STAR THERAPEUTICS LTD·Filed 2021·Granted Jan 7, 2025·1 cites·24 claims
- 0684US11629193B2EGFR binding moleculesF STAR BETA LTD·Filed 2017·Granted Apr 18, 2023·10 cites·20 claims
- 0782US12103976B2Fc binding fragments comprising a CD137 antigen-binding siteF STAR THERAPEUTICS LTD·Filed 2019·Granted Oct 1, 2024·4 cites·22 claims
- 0879US8324350B2Dual-specific IL-1α/IL-1β antibodiesHSIEH CHUNG-MING·Filed 2007·Granted Dec 4, 2012·3 cites·92 claims
- 0973US12252537B2Antibody molecules that bind CD137 and OX40F STAR BETA LTD·Filed 2019·Granted Mar 18, 2025·1 cites·22 claims
- 1070US12312408B2Multispecific anti-TCR delta variable 1 antibodiesGAMMADELTA THERAPEUTICS LTD·Filed 2023·Granted May 27, 2025·0 cites·14 claims
- 1170US2024376215A1Multispecific anti-tcr delta variable 1 antibodiesGAMMADELTA THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1269US12297283B2Fc binding fragments comprising an OX40 antigen-binding siteINVOX PHARMA LTD·Filed 2019·Granted May 13, 2025·1 cites·15 claims
- 1368US2023348601A1Bispecific antibody for icos and pd-l1KYMAB LTD·Filed 2023·Application pending·0 cites
- 1468US2025368730A1Anti-mesothelin antibodiesINVOX PHARMA LTD·Filed 2025·Application pending·0 cites
- 1566US2025084176A1Fc binding fragments comprising a cd137 antigen-binding siteINVOX PHARMA LTD·Filed 2024·Application pending·0 cites
- 1663US2023406935A1Fc binding fragments comprising a pd-l1 antigen-binding siteF STAR THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1761US2023357413A1Egfr binding moleculesF STAR THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1861US2022185894A1Binding molecules binding pd-l1 and lag-3F STAR THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1958US2025346679A1Antibody molecules that bind pd-l1 and cd137INVOX PHARMA LTD·Filed 2025·Application pending·0 cites
- 2057US12325742B2Anti-mesothelin antibodiesINVOX PHARMA LTD·Filed 2019·Granted Jun 10, 2025·0 cites·20 claims
- 2157US2025361312A1Fc binding fragments comprising an ox40 antigen-binding siteINVOX PHARMA LTD·Filed 2025·Application pending·0 cites
- 2255US2013171146A1Dual-specific il-1a/ il-1b antibodiesHSIEH CHUNG-MING·Filed 2012·Application pending·0 cites
- 2352US12344672B2Antibody molecules that bind PD-L1 and CD137INVOX PHARMA LTD·Filed 2019·Granted Jul 1, 2025·0 cites·25 claims
- 2451US2023028110A1Anti-tcr delta variable 1 antibodiesADAPTATE BIOTHERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2541US2019338049A1Conditional agonists of immune responsesF STAR BETA LTD·Filed 2018·Application pending·0 cites
- 2638US12319739B2Mesothelin and CD137 binding moleculesF STAR DELTA LTD·Filed 2019·Granted Jun 3, 2025·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Mihriban Tuna files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →